As healthcare challenges continue to grow, so does the need for innovative ways to meet them. Observe Medical develops medtech solutions that help ensure healthcare professionals and patients benefit from the highest standards of care safely and cost-effectively.
· Observe Medical will develop and commercialize proprietary, innovative medtech products to the global market · International distributor and partner network with a Nordic direct sales organization · The agreement is set to accelerate the global commercial roll-out of the combined portfolio, including Sippi® US market launch and the entry of Biim in Europe Oslo,…
Read moreReference is made to the stock exchange announcement published by Observe Medical ASA (the "Company") earlier today, on 14 January 2022, regarding the resolution by the Company's board of directors to propose that the Company carries out a share capital increase, by way of a fully underwritten rights issue, to raise gross proceeds of NOK…
Read moreNOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
Read moreObserve Medical is a Nordic based medtech developer with development, quality, regulatory and commercial operations in Gothenburg, Sweden, and headquarters in Oslo, Norway.
The prevalence and cost of hospital acquired infection are growing challenges for healthcare facilities. Sippi infection inhibiting automated digital urine meter system from Observe Medical can help.